Tuesday, September 30, 2025

< + > Big Announcements and New Products at the eClinicalWorks National Conference

This weekend I was excited to head back to the eClinicalWorks National Conference in Orlando, FL.  Thousands of eClinicalWorks users attend the national conference to hear the latest product announcements, connect with peers, and be able to talk directly with the eClinicalWorks staff.

One of the unique things that eClinicalWorks staff do at the conference is in the hallway leading to breakfast and the opening keynote is the eCW staff all line up and cheer as their customers walk past.  It’s kind of like a football player running out of the tunnel feeling as the crowd cheers.  It’s a pretty fun way for eCW to honor their customers.  Plus, this year before the opening keynote, they were streaming some entertainment from the hallway where they had a band and even broke out in a custom song about the user conference and the various eClinicalWorks products.

A really creative and entertaining way to start a user conference.

As I’ve said before, each EHR user conference seems to reflect the culture and personality of the organization and their leaders.  Girish Navani, CEO and Co-Founder of eClinicalWorks is an amazing showman and the opening keynote is a great show full of cheering along as he announces new features, demos the new features, and makes new product announcements.  Below you’ll find my social media summary of the key announcements during the keynote along with a little extra commentary.

Kudos to the eClinicalWorks team for an amazing stage set up.  Multiple screens and a colorful stage was a great setup for their announcements.  The glasses were part of their big announcements as you’ll see.

One of the most interesting things I share from user conferences is the stats they share with the audience.  2000 new locations for eCW in the last 12 months is a big deal at any time, but especially in the current market.  Not to mention passing $1 billion as a private company.

I think the idea of making the EHR invisible was a big theme at this year’s conference.  You’ll see it in a number of the solutions they showed.  Logging into the EHR over and over again can be a real hassle.  It’s great to see them embracing facial recognition and liveness to make the login process more seamless and invisible.  Not to mention more secure.

I thought this was a really fascinating comparison to Google Search’s move from providing links to providing summaries.  That definitely sounds like what eClinicalWorks is doing with PRISMA.  It used to search all the data and now it’s summarizing it.  I’m still chewing on Navani’s comment that “healthcare has an infinite flow of data.”  When you think about what could be measured in our body, that statement is really poignant.

A lot of people in the interoperability world are looking at how the EHR vendors are going to approach TEFCA and QHINs.  eClinicalWorks strategy is all in as a QHIN with what they’re calling PRISMA Net.  My guess is that may spell the evenutally sunsetting of CommonWell and CareQuality for eCW, but we’ll see how that plays out.  Lots to still be determined there.

Major credit to Sunoh.ai, the AI Medical Scribe/Ambient Clinical Voice solution that’s integrated with eClinicalWorks was given on stage.  What’s interesting is that it probably didn’t need much attention on stage because it was being adopted so quickly.  The quote from the doctor is amazing to see.  What other IT feature has gotten more quotes like this?  I’m interested to see if they’re making progress with other EHR vendors implementing it, but not something they’d announce at their user conference.

The key announcements for Sunoh.ai basically revolved around deeper integration with eClinicalWorks.  There was a lot of happy cheers for Sunoh to be able to automatically do the various coding and orders.  These deep integrations is what every AI medical scribe is working on and is going to make a huge difference.

I’d seen quite a bit of healow Genie before, so this wasn’t that new for me.  You can see how valuable this can be for an organization and the deep integration with the EHR and PM really does set it apart.

It’s fun for me to think back on this progress as well.  I think at my first eClinicalWorks user conference many years ago they announced copy and paste (there were some security and privacy reasons why they didn’t allow it for a long time) to celebration from the crowd.  This year felt like multiple leaps forward when it comes to the impact their announcements will have on the end user, the interface, and patients.

The move to connect with payers is happening with a number of EHRs.  It can solve a lot of the challenges healthcare organizations face.  I was surprised with how many health plans eCW has connected with.  If you look at our past interviews, you can learn how impactful it is for an organization when the payer is connected to healow Insights.

This was kind of the data dump of new features.  I probably missed a few, but it gives you an idea of what they’ve accomplished.  A lot of focus on making things more efficient.  The AI curated content on eCW University is fascinating and pretty unique.  I loved that the patient visit summaries are available in 8 languages.

The expansion into more specialties continues.  It’s always interesting to see what unique needs each specialty has and these 3 have really unique ones.

I think we saw a similar slide to this last year, but it’s amazing to see how many value based care efforts are going on and how eCW supports them.

These announcements of eClinicalWorks expansion were almost an after thought on stage.  That kind of makes sense since if you’re a user, do you really want to hear that your vendor is spending time on areas that won’t help you specifically?  The big announcement in there though was Navani saying that they’re planning to release a Critical Access Hospital product sometime next year.  That will be interesting to watch.

RCM is a big focus in healthcare right now because there’s a lot of opportunity and revenue management has become so important.  Lots of improvements to eCW’s RCM efforts were shared on stage.

I think I share these numbers every year, and every year they leave me struck.  1 million daily healow app users is pretty amazing to consider.

We’ve talked a lot about doctor reviews at our Swaay.Health LIVE conference over the years.  It’s a big important space for medical practices.  Done right, it can make a big difference in driving patients to your practice.  Was fascinating to see a preview of what eClinicalWorks has created to be able to better manage a clinic and their doctors on the various patient review sites.

We finally saw the details of one way the smart glasses could be used.  Clinicians and others like practice managers can use their smart glasses to get a “podcast” which basically summarizes their messages, appointments, reports, etc.  Plus, what makes it unique is you can actually interact with it and reply to messages for example.  It was a cool demo, but I’m really interested to see what users think of it when they get it in their hands.

They of course saved what I think was the coolest demo for near the end of the keynote.  You can read about it in the above description.  However, the basic idea of only having smart glasses and possibly a screen in the exam room and everything done with voice including the screen pulling up info from the EHR based on the ambient signals was pretty mind bending.

I’m confident there’s a lot of refinement that’s going to be needed.  Plus, it’s a huge paradigm shift for doctors, but it definitely enlivens the mind to what could be possible in this new world of AI.  Could a doctor really see a patient with no clicks?  The demo definitely illustrated the opportunity.

That’s my summary of the eClinicalWorks National Conference keynote.  What did you think of their announcements?  Are there any that stood out to you?  What do you think of the computerless exam room and ambient computing?  Share your thoughts with us on social media.

eClinicalWorks is a proud sponsor of Healthcare Scene.



< + > Why Public Health Data Needs to Modernize

The following is a guest article by Keith Boone, Standards Guru and Enterprise Architect at Audacious Inquiry, a PointClickCare Company

The complexity, volume, and interoperability requirements of healthcare data have grown so much over the past decade that they’re outstripping the capabilities of the legacy software systems that manage the information.

Public health agencies have done a remarkable job of operating and maintaining their current systems, some of which date back three decades, but the need to modernize becomes more apparent every day.

This is evident as the public sector lags private industry in its adoption of new data handling interfaces, specifically, the transition from HL7 V2 and CDA health data standards to FHIR (Fast Healthcare Interoperability Resources). Ironically, the push for FHIR is being driven by the public sector, namely, the Federal government, which is mandating the adoption of FHIR-based APIs for healthcare data exchange. Private healthcare organizations, including health plans, are also moving to FHIR.

The reasons for the transition are clear. FHIR is superior to HL7 V2 in multiple ways. The web-based FHIR offers standardized APIs, is easier to integrate with modern applications, including mobile and cloud-based apps, and overall is more flexible and adaptable to a fast-changing healthcare landscape. 

Continued reliance on legacy systems is problematic for a number of reasons. A lack of interoperability among systems can leave critical data in silos and unavailable. In the case of a public health emergency, this can cause delayed responses and an inability to accurately assess and address the crisis.

In addition, these legacy systems lack the sophisticated analytical capabilities required to advance public health initiatives such as population health, transitioning to value-based care, identifying health inequities, and addressing social determinants of health.

Then there is cost. Keeping decades-old, HL7 V2-based interfaces – operating and modifying them to do things they were never designed for – is expensive and requires constant attention from IT departments. At some point, it becomes untenable.

It’s clear that if healthcare is to achieve its interoperability goals, it must upgrade its technology.

However, public health agencies face several barriers to modernization, in addition to cost. Public health data is still being driven into HL7 V2 formats by legacy regulations and standards, even as the Centers for Disease Control and Prevention and the Assistant Secretary for Technology Policy push for FHIR.

Also, converting HL7 V2 and CDA to FHIR is neither simple nor easy. Integration and interface engines require complex and painstaking mapping from legacy to modern standards. Integrating via platform-as-a-service is difficult and costly. While federal funding sources for the work do exist, healthcare budgets are under stress, which makes it imperative that health agencies handle the modernization as efficiently as possible.

Agencies reluctant to abandon the reliable HL7 V2 standards can take comfort in the fact that it will take years to transition completely to FHIR, and both will be required for the foreseeable future.

Public health agencies don’t have to switch everything immediately from HL7 V2 and CDA to FHIR, but those that have not yet started should at least begin planning. Agencies that make the move sooner rather than later will be better positioned to meet the growing demands on public health data.

Agencies can make modernization faster and easier by finding an expert partner who can help them accomplish it with minimal disruption while producing optimal results. This sort of collaboration can eliminate context switching between systems to access data, avoid complex integrations across multiple systems using different data formats, and aggregate and merge datasets across data sources in different formats without manual intervention.

Those modernized agencies and the people they serve will benefit from improved efficiency and streamlined processes, enhanced data quality for informed decision making, and increased collaboration with other agencies and the private sector.



< + > Prominence Advisors Acquires Tegra Analytics, Marking Entry into Life Sciences

The Partnership Brings Together Healthcare and Life Sciences Expertise to Drive Data Enablement Innovation

Prominence Advisorsthe nation’s leader in healthcare data enablement, announced the acquisition of Tegra Analytics, a life sciences analytics consultancy. The partnership extends Prominence’s proven data enablement platform into life sciences, strengthening its service across providers, payers, and life sciences organizations.

Founded in 2002, Tegra Analytics brings deep statistical expertise and extensive domain experience across the commercial and clinical lifecycles of pharmaceutical, biotech, and medical device organizations. Known for delivering highly customized analytical solutions – including innovative sales operations initiatives, robust data platforms, actionable dashboards, and advanced analytical support – Tegra helps life sciences companies operationalize data to drive performance and innovation.

By joining forces, Prominence gains immediate access to a robust portfolio of advanced analytics capabilities in the life sciences space, enhancing its ability to serve pharmaceutical, biotech, and commercial organizations through end-to-end data strategy.

“With Tegra Analytics, we’re expanding the reach of our data platform to unify healthcare and life sciences data – helping organizations accelerate discoveries, improve patient outcomes, and reduce costs,” said Bobby Bacci, CEO at Prominence Advisors.

“By combining our strategic consulting expertise with Prominence’s robust data assets and technology infrastructure, we’re uniquely positioned to help life sciences companies make faster, smarter, and more impactful decisions. We’re thrilled about the expanded opportunities this creates for our clients and our team,” said Matt Hutcheson, CEO at Tegra Analytics.

Together, Prominence and Tegra will support data modernization and infrastructure development across the healthcare sector and deliver actionable insights through AI-driven analytics.

About Prominence Advisors

Prominence Advisors, headquartered in Chicago, is the Healthcare Data Enablement company, helping healthcare organizations harness the power of their data to improve patient outcomes, reduce the cost of care, and increase operational efficiency. Uniquely positioned at the intersection of EMR expertise, data and analytics, and intelligent automation, Prominence partners with leading health systems nationwide to solve their most complex challenges. The firm is highly rated by KLAS in four categories, winning two Best in KLAS awards for HIT Staffing and Technical Services, reflecting its commitment to excellence and measurable results. Through deep partnerships with leading technology providers – including AWS, Microsoft, Databricks, Snowflake, Tableau, Salesforce, Informatica, and Collibra – Prominence enables organizations to modernize in the cloud, harmonize data post-merger, ensure revenue integrity, and accelerate adoption of AI-driven automation. By embedding insights directly into workflows, designing modern data architectures, and orchestrating intelligent processes, Prominence empowers healthcare organizations to turn insights into innovation and achieve meaningful ROI. For more information, please visit prominenceadvisors.com

About Tegra Analytics

Tegra Analytics, with offices in Columbia, SCPhiladelphia, and Cincinnati, is a boutique consulting firm dedicated exclusively to analytics and commercial operations support for the life sciences industry. For more than 23 years, Tegra has partnered with leading pharmaceutical, biopharma, and medical device companies – including seven of the top ten global pharma firms – delivering customized solutions that support territory alignments, call planning, targeting and segmentation, incentive compensation, forecasting, and reporting. With a team of U.S.-based statisticians, programmers, analysts, and consultants, Tegra has delivered hundreds of successful projects spanning forecasting, segmentation, alignment, and incentive compensation, helping life sciences organizations optimize their commercial strategies and performance. The company is recognized for its expertise across dozens of therapeutic areas, including oncology, neurology, rare disease, women’s health, cardiology, and more. Guided by its values of involvement, customization, expertise, flexibility, and trust, Tegra serves as a long-term, trusted extension of client teams, combining technical excellence with tailored solutions to improve outcomes. For more information, please visit tegraanalytics.com.

Originally announced September 3rd, 2025



Monday, September 29, 2025

< + > Paul Wilder on Why Interoperability Still Feels Stuck

Why have we not made more progress on interoperability? Will information blocking enforcement help? These are two questions the Healthcare IT Today team has been asking a lot lately.

Paul Wilder, Executive Director of Commonwell Health Alliance didn’t shy away when we raised them.

In our conversation, Paul points to labs and pharmacies as the missing voices in today’s data-exchange framework. He argues that we’re hamstringing their ability to share data by forcing them into document-based interoperability standards rather than discrete data – the kind AI and clinicians both need. And he offers a frank take on where enforcement fits in.

Learn more about Commonwell Health Alliance at https://www.commonwellalliance.org/



< + > Enforcement of Information Blocking – Healthcare IT Today Podcast Episode 176

For the 176th episode of the Healthcare IT Today Podcast, we are talking about the U.S. Department of Health and Human Services (HHS) announcement to enforce information blocking! We kick this episode off by sharing our personal reactions to HHS’s crackdown on health data blocking. Next, we debate whether or not this is going to be effective in stopping information blocking. Then we discuss if patients are getting the right information shared with them. Lastly, we focus our attention on health IT vendors to discuss if they have access to the right patient information.

Here’s a preview of the topics and questions we discuss in this episode:

  • What’s your reaction to HHS’s crackdown on health data blocking?
  • Is this going to be effective at stopping information blocking?
  • Is the right information being shared with patients?
  • Do health IT vendors have access to the right patient information?

Now, without further ado, we’re excited to share with you the next episode of the Healthcare IT Today podcast.

We publish a new Healthcare IT Today podcast every ~2 weeks. Thanks to our friends at Healthcare Now Radio, you’ll be able to listen to the latest episodes of Healthcare IT Today on their radio station for the first two weeks. Then, we’ll be publishing each episode as a podcast and YouTube video here after it finishes on the radio.

You can also subscribe to the Healthcare IT Today podcast on any of the following platforms:

Thanks for listening to Healthcare IT Today and if you enjoy the content we’re sharing, please rate the podcast on your favorite podcasting platform.

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on HealthcareITToday.com.

If you work in Healthcare IT, we’d love to hear where you agree and/or disagree with the perspectives we shared. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, with @Colin_Hung or @techguy on Twitter, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!

Listen to Our Latest Episodes:



< + > Healthcare’s Device Crisis Is a Patient Safety Crisis

The following is a guest article by Apu Pavithran, Founder and CEO at Hexnode

Cybersecurity and physical security are increasingly linked in modern healthcare. Bad actors know that mobile devices and medical endpoints can serve as entry points into an organization’s ecosystem and allow them to hold the entire network hostage.

We saw this last year when Change Healthcare fell victim to a ransomware attack, resulting in data theft and estimated losses of more than $800 million. Attackers succeeded through basic endpoint security failures – cracking a single password on a remote account without multi-factor authentication – which saw not only financial losses but also the cancellation of urgent surgeries and critical patient services.

In this climate of increasing ransomware and successful breaches – with healthcare attacks up 150% year-over-year – device security must be seen as patient security. It’s therefore not acceptable to treat outdated devices and open backdoors as the sector norm. Poorly managed devices represent healthcare’s most preventable security crisis – let’s look at how leaders can finally close this gap.

Why Mobile Devices are in Hacker Crosshairs

Hackers know that healthcare downtime isn’t only expensive but a literal matter of life and death. Once inside, they demand payout or threaten lockout, knowing full well that healthcare is more motivated than most industries to get their systems back up and running. But the sector isn’t moving fast enough to protect ecosystems from known vulnerabilities and upgrade old devices. A recent report revealed that approximately half of all mobile devices are running outdated operating systems, a big problem since about one-third of ransomware attacks start with a known yet unpatched vulnerability.

It’s a numbers game for hackers and the numbers are increasingly in their favor. They know that, post-pandemic, there are more healthcare endpoints online to exploit, and AI is a productivity boon that enables them to scale attacks with unprecedented efficiency. This only makes ransomware a more frequent problem for which healthcare organizations are increasingly willing to pay. In 2024, 11 percent more organizations paid ransoms compared to the previous year, with an average payout of $4.4 million.

Moreover, healthcare organizations are finding it harder to come back from hacks. Fast recoveries are fewer and further between with only 22% of healthcare organizations recovering from ransomware in less than a week in 2024, a dramatic decline from 54% in 2022. Meanwhile, 37% reported that it took them more than a month to return to “normal”, up from 28% the previous year.

Unfortunately, patients suffer in the meantime. According to Proofpoint, two-thirds of healthcare organizations experienced care disruptions following security incidents, with more than half reporting delayed procedures that led to poor patient outcomes. Even more concerning, half of the affected organizations saw complications during medical procedures increase, while nearly a quarter reported higher patient mortality rates. Clearly, getting security right isn’t only about creating a strong environment for patient data, but also ensuring a reliable foundation for patient care.

The Politics of Medical Devices

This isn’t to say that admins bear all the blame. From patient monitors to infusion pumps and imaging systems, some devices run on hardware that can last years or decades, but software with a much shorter lifespan. Of course, some of these devices were never intended to connect to the internet, but replacing them or updating them isn’t easy. In these situations, we need admins working with healthcare leaders to develop solutions that stop this emerging attack vector while enabling these life-saving machines to continue providing care.

It’s also worth noting that political cost-cutting doesn’t help matters. A recent House hearing on medical device cybersecurity highlighted concerns that FDA staff cuts could undermine federal cybersecurity efforts just when hospitals need more support, not less.

Yet, despite federal uncertainty, there are immediate steps admins can take. As one expert testified, many hospitals don’t even know how many vulnerable devices they have or where they’re located – representing basic inventory management that’s entirely under IT’s purview.

My advice is that admins should move immediately to better protect their current assets. In the face of clear software and device shortcomings that they control, it’s past time to step up and fight back.

How Admins Can Take Back Device Control

Begin by thoroughly understanding what you have. Connect your devices to a central platform to gain a singular view of what’s online and better protect them. Solutions like unified endpoint management not only provide an up-to-date overview of the ecosystem but also allow automatic software patching and password policy enforcement – two avenues that ransomware hackers often exploit. These platforms also enable compliance reporting, emergency access protocols, and remote device wipe capabilities – non-negotiable foundations in protecting always-on devices from always-active hackers.

Also, reconsider the make and model of devices. Android in healthcare is proving more than capable with top marks for customization, compatibility, and secure handling of patient data. Of course, it doesn’t hurt that Android devices are also cheaper than competitors like Apple. Android devices, particularly when entire fleets are unified by a central platform, excel at meeting healthcare’s unique demands for durability, specialized workflows, and cost-efficiency. Retooling with standardized devices that follow automated policies is a proven way to address many of the problems we’ve discussed before they become critical vulnerabilities.

Additionally, protect the wider network from legacy devices with segmentation. When older medical equipment can’t be immediately updated, keeping it on a separate network limits the potential damage from any compromise.

Considering the seriousness of the ransomware threat and the relative ease with which many of the device backdoors can be closed, it’s just not good enough for outdated software and poor cyberhygiene to be the status quo. Device security is inextricably linked with patient outcomes – it’s up to all of us to lift our game and redouble our device defenses.

About Apu Pavithran

Apu Pavithran is the Founder and CEO at Hexnode, the award-winning Unified Endpoint Management (UEM) platform developed by Mitsogo Inc. Hexnode helps businesses manage mobile, desktop, and workplace devices from a single place.



< + > Cascala Health Raises $8.6M in Seed Funding

Cascala Health, a Boston, MA-based healthcare technology company, raised $8.6M in seed financing.

The round was co‑led by Flare Capital Partners and Eniac Ventures, with participation from Omega Healthcare Investors, Ziegler Link-age Fund, Tau Ventures, and Digital Health Venture Partners, bringing Cascala’s total funding to $11.23M since its launch in mid-2024.

The company intends to use the funds to accelerate product development, expand its clinical intelligence capabilities, and support the growth of its customer implementation team.

Led by Matt A. Murphy, CEO and Co-Founder, Cascala Health delivers a clinically responsible AI intelligence layer for care teams and post-acute care operators. It combines AI-powered insights, real-time communication tools, and clinical reasoning to guide care teams through each moment in the patient journey. Its AI‑enabled clinical intelligence platform integrates with any web‑based EMR or population health platform to streamline workflows, surface personalized interventions, and support risk‑bearing organizations in delivering better care transitions and ongoing disease management.

In active deployments with early customers, Cascala’s care transitions platform already orchestrates care for more than 300,000 patients across thousands of post-acute transitions. It also extends into the larger patient care team, empowering more than 3,000 primary-care clinicians to actively engage in their patients’ post-acute journey.

Originally announced August 20th, 2025



Sunday, September 28, 2025

< + > Bonus Features – September 28, 2025 – 90% of clains denials require human review before resubmission, 73% of biopharma teams got false insights thanks to incomplete data, plus 33 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.

Studies

Partnerships

Products

Implementations

Company News

People

If you have news that you’d like us to consider for a future edition of Healthcare IT Today Bonus Features, please submit them on this page. Please include any relevant links and let us know if news is under embargo. Note that submissions received after the close of business on Thursday may not be included in Bonus Features until the following week.



Saturday, September 27, 2025

< + > Weekly Roundup – September 27, 2025

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.

AI Takes Center Stage at OntarioMD’s Digital Health Conference. Colin Hung noted that the conversation about AI has matured from hype to hard questions, particularly when it comes to optimization, governance, and guardrails. Read more…

A Look at Epic’s Approach to Interoperability. Rob Klootwyk at Epic and Dr. Matthew Eisenberg at Stanford Health Care sat down with John Lynn to talk about facilitating data sharing, ensuring patient privacy, leveraging automation, and connecting providers to TEFCA. Read more…

Growth and Innovation Take Center Stage at Charmalot 2025. Colin also ventured to the Bay Area for CharmHealth’s user conference. The company announced physician collaboration and real-world data research initiatives and highlighted its efforts to attract larger practices. Read more…

Unpacking This Year’s MEDITECH Live Keynotes. Reporting from the company’s user conference in Boston’s leafy suburbs, John learned about MEDITECH’s push to support intuitive care, deploy AI in a thoughtful way, and help providers cleanse their data. Read more…

Life Sciences Today Podcast: Long-Term Patient Follow-Up. Danny Lieberman talked to Pamela Tenaerts at Medable about empowering patients to use their phones to report outcomes and do blood work and imaging in local clinics, making trials more convenient and less expensive. Read more…

CIO Podcast: Perspectives on AI. David Tucker joined John to shed some light on the best-of-breed vs. all-in-one approach to AI. They also discussed how to maintain patience with users – and boards – demanding AI tools. Read more…

Keeping Low-Code Platforms Safe in Healthcare IT. The low-code approach helps teams build digital assets quickly. Measures such as separated testing environments, access controls, and audit trails can keep data secure in a fast-paced setting, noted John Miniadis at Stackdrop. Read more…

How Real-World Data Drives Success in Active-Controlled Trials. These types of clinical trials compare a new therapy against the existing standard of care, rather than a placebo. As ACTs can lack safety data, insights from real-world data add context and contribute to clinical guidance, said Ashley Daigneau at Verana Health. Read more…

Building a Future-Proof Healthcare Network. Copper-based LANs need to be replaced every several years, which leads to service disruption. Optical LAN is less expensive to deploy, lasts longer, supports higher speeds, and comes with fewer failure points, according to Cemil Canturk at Nokia. Read more…

Automation Can Help Providers Keep Pace With Prior Auth Reform. As major players work to streamline prior authorization, providers need to modernize internal workflows or risk being left behind, said Grace Nam at Laserfiche. The first step: Finding and solving bottlenecks in manual data transfers. Read more…

This Week’s Health IT Jobs for September 24, 2025: Novant Health is seeking an SVP and Chief Health Informatics Officer, to be based in North Carolina. Read more…

Bonus Features for September 21, 2025: 19% of cyberattacks cost healthcare orgs at least $200,000; meanwhile, only 49% of healthcare leaders think AI will solve their cost efficiency problems. Read more…

Funding and M&A Activity:

Thanks for reading and be sure to check out our latest Healthcare IT Today Weekly Roundups.



Friday, September 26, 2025

< + > AI Takes Center Stage at OntarioMD’s Digital Health Conference 2025

Walking the exhibit hall at OntarioMD’s Digital Health Conference 2025 (DHC2025), one theme was impossible to miss: AI. Vendors from across Canada showcased AI scribes and automation tools designed to ease documentation burdens, fill out forms, and even trigger EMR actions.

Video features: Mahshid Yassaei from Tali.ai, Dr. Noah Crampton from Mutuo Health, Scott Schroeder from Mikata, Jesse Creighton and Maureen Green from Heidi Health, Christine McKenzie from CIHI, Mark Casselman from Akinox, Robert Fox and Dr. Chandi Chandrasena from OntarioMD.

AI Moves From Hype to Hard Questions

What stood out this year wasn’t just the excitement over AI, it was the maturity of the conversation. Last year, the buzz centered on “what’s possible.” This year, it was about optimization, governance, and guardrails.

As Mahshid Yassaei, Co-Founder & CEO of Tali.ai (makers of a leading AI Scribe in Canada), put it – building any AI scribe is easy, but building a great one that respects clinician style, accuracy, and trust is the real challenge

Collaboration as the Secret Sauce

Christine McKenzie from the Canadian Institute for Health Information (CIHI) reinforced how important standards are to that trust. She explained, “We’re co-designing the common data standards and data architecture with people with different experiences and expertise—from clinicians to patient partners, vendors, and provinces—to really define the source of truth for health information.”

Robert Fox, CEO of OntarioMD, shared a complementary perspective, calling what’s happening in Canadian health IT a broader convergence: “We’re seeing a lot of people coming together, systems coming together, care providers coming together… and I think that’s the secret sauce to really accelerating our healthcare system.”

Both leaders emphasized that integration and collaboration are not optional—they’re essential to delivering connected care

Strengthening Family Physicians – the Foundation of the System

It was very encouraging to hear the focus being placed on revitalizing primary care in Ontario. Many of the attendees we spoke to noted that family physicians remain the front door to the entire healthcare system, and their digital needs must be prioritized.

If last year was about marveling at what AI could do, this year showed a sector determined to make it work responsibly. That maturity was reflected not just in vendor pitches, but in the way leaders like Christine McKenzie and Robert Fox spoke about standards, convergence, and connected care. And with primary care firmly in the spotlight, the conversations at DHC2025 suggested that Canada’s digital health community is no longer experimenting. Instead, Canadians are building the guardrails, integrations, and trust needed to make AI and interoperability part of everyday practice.

Learn more about OntarioMD at https://www.ontariomd.ca/



< + > EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access

Combined Company Offers Next-Generation Commercialization Model that Directly Connects Life Sciences to Payers and Patients to Accelerate Access, Improve Affordability, and Transform Drug Value Across the Care Continuum

Waltz Health Co-Founder and CEO Mark Thierer Appointed CEO at EVERSANA; Jim Lang, Former CEO, Will Continue to Serve as a Board Member

EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system.

EVERSANA is a pioneering leader in the pharma commercialization industry, serving the top 50 pharma and biotech companies globally with a full suite of end-to-end commercialization capabilities. By embedding Waltz Health’s technology and broad payer footprint, the combined company is positioned to break through the industry’s misaligned incentives and fragmented patient experiences. The merger will be especially impactful for lowering the cost of specialty medications and high-cost drug classes like GLP-1s. Waltz’s technology platform, including its AI-powered prescription routing and affordability solution, connects patients, health insurers, self-insured employers, governments, and pharmacy benefit managers (PBMs).

Mark Thierer, Co-Founder and CEO at Waltz Health and Chairman at EVERSANA, will serve as CEO of the combined organization. Thierer brings decades of leadership experience in healthcare innovation, including previously serving as CEO at OptumRx, following UnitedHealth Group’s $13 billion acquisition of Catamaran.

“This is a pivotal moment for the healthcare industry,” said Thierer. “By combining EVERSANA’s pharma services with Waltz’s technology-enabled payer solutions, we’re creating a unified platform that connects life sciences innovation directly to the organizations and individuals we’re meant to serve. This model is built to accelerate access, improve outcomes, and deliver smarter, more transparent drug commercialization at every step.”

A Disruptive End-to-End Model for Life Sciences

EVERSANA has long served as the go-to partner for pharmaceutical and biotech companies navigating product launches, commercialization, market access, and patient support. Waltz Health complements this strong foundation with a suite of technology-enabled solutions, ranging from AI-powered pharmacy switches and affordability tools to payer-facing marketplaces, that streamline patient access, lower drug costs for patients and plan sponsors, and greatly improve the patient experience.

The union not only connects life science companies directly to payers – including commercial insurers, self-insured employers, and PBMs – it also gives them unmatched reach and execution power across:

  • Pharma Commercialization: The combined organization integrates patient services, field teams, digital marketing, reimbursement support, and real-world evidence – all powered by modern software infrastructure
  • Payer Connectivity: Waltz’s direct-to-payer and direct-to-patients solutions will supercharge the EVERSANA COMPLETE Commercialization model, giving manufacturers turnkey channels to reach millions of covered lives
  • Drug Affordability & Adherence: Together, the companies enable net-price models, copay optimization, and integrated pharmacy routing that reduce patient abandonment and increase therapeutic persistence
  • Specialty Pharmacy Infrastructure: Through Waltz Connect, a technology-powered, end-to-end solution that gives payers flexibility and optimized specialty pharmacy savings by unlocking competition, Eversana now has a fully integrated, URAC-accredited specialty pharmacy network designed for high-cost therapies and limited distribution drugs

A New Standard for Drug Value

The merger comes at a time when the pharmaceutical industry is facing increasing pressure over drug pricing, patient affordability, and channel inefficiencies. The new organization aims to address these issues head-on with a value-focused model that balances innovation, transparency, and access across the entire lifecycle of care.

“This combination brings together the scale and services of EVERSANA with Waltz Health’s payer-integrated platforms to create a company purpose-built for the future of life sciences,” said Thierer. “Together, we are launching a new-to-the-world model that directly connects manufacturers to patients and payers, delivering significant cost savings and improved patient outcomes to the healthcare system.”

Unmatched Industry Leadership

Waltz Health’s leadership team has been at the forefront of innovation, building technology that now serves as a foundation of the prescription benefit landscape today. EVERSANA brings a deep bench of pharmaceutical commercialization expertise, delivering high-value solutions across the life sciences landscape. Together, this combined leadership team is poised to redefine the pharmaceutical supply chain and drive its next chapter of transformation.

About EVERSANA

EVERSANA is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.

About Waltz Health

Waltz Health is a digital health company developing technologies and services that support better-informed decisions on prescription care. Designed for payers, pharmacies, pharmacy benefit managers, and self-insured employers, the company offers AI-driven marketplaces to lower overall drug costs, providing better pricing options and more information for consumers while also helping payers take control of their pharmacy benefits. Founded in 2021 by Mark Thierer and Jonathon Thierer, Waltz Health is headquartered in Chicago and is backed by GV, Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital, and Twine Ventures. For more information, visit waltzhealth.com.

Originally announced August 26th, 2025



< + > Advent International to Acquire PatientPoint, the Point of Change Company, Elevating Healthcare Through the Nation’s Largest Digital Point-of-Care Engagement Network

Advent International, a leading global private equity investor, today announced that it has signed a definitive agreement to acquire PatientPoint, Inc., the nation’s largest digital point-of-care network, strategically delivering behavior-changing content and measurable outcomes for patients, providers, and health brands, from an investor group led by L Catterton and Littlejohn & Co., LLC. Terms of the transaction were not disclosed.

PatientPoint has more than 35 years of experience transforming the point-of-care experience by delivering actionable, educational content, and diagnostic tools to patients and healthcare providers. Through an interconnected nationwide network of 30,000 physician offices and 125,000 providers, PatientPoint delivers measurable outcomes while connecting patients, providers, and health brands with relevant information at critical moments of care. PatientPoint’s platform improves health awareness and drives positive behavior changes while enabling pharmaceutical and health brand sponsors, health associations, advocacy groups, and other organizations to reach highly targeted audiences.

Chris Comenos, Director at Advent, said, “We are thrilled to partner with PatientPoint, a leader in digital point-of-care engagement, as it continues its mission of helping patients take a more active role in understanding and managing their healthcare. We’re excited to help the Company provide increasingly targeted messaging about treatment options and advanced therapies, offering sponsors and partners more efficient, personalized, and measurable campaigns. Given the platform’s position in a patient’s healthcare journey, we also believe it has strong potential to deliver new, innovative solutions that will drive beneficial health outcomes over time.”

Carmine Petrone, Managing Director at Advent, added, “Drawing on Advent’s deep experience scaling innovative healthcare and pharmaceutical services companies, we look forward to working closely with CEO Sean Slovenski and the PatientPoint team to accelerate the Company’s network expansion and drive product innovation through this large and growing channel – delivering even greater value to providers, partners, and patients nationwide.”

Sean Slovenski, CEO at PatientPoint, said, “From the beginning, PatientPoint has been committed to a clear mission: driving better health outcomes by delivering trusted, behavior-changing education in the doctor’s office, where decisions are made. With Advent, we can accelerate growth, expand our network, and continue to deliver measurable value for providers, patients, and health brands.”

“At PatientPoint, our clients and healthcare providers are at the heart of everything we do,” said Linda Ruschau, Chief Commercial Officer at PatientPoint. “This new partnership is an incredible catalyst for growth. Advent gives us the resources to innovate faster, expand our reach, and deliver even more value to our clients as they look to engage audiences at the point of care and beyond.”

“Our partnership with PatientPoint has been defined by a shared belief in its mission to transform the point-of-care experience for patients, providers, and healthcare sponsors,” said Andrew Taub, a Managing Partner at L Catterton. “We are proud to have leveraged our deep understanding of consumers to support the Company’s growth into becoming the clear market leader in patient engagement and are grateful to the team for their vision and dedication.”

“PatientPoint’s growth over the past several years has been remarkable, and we have been privileged to support the Company through this important phase of its evolution,” said Drew Greenwood, Managing Director at Littlejohn. “We look forward to seeing the Company continue to expand its impact and leadership in the years ahead.”

PatientPoint will continue to be led by its existing management team, with support from Advent’s deep bench of advisors with relevant healthcare and digital expertise.

The acquisition underscores Advent’s conviction in the rapidly growing point-of-care market, which is benefiting from strong industry tailwinds as promotional spend shifts toward more digital and measurable channels. This investment builds upon Advent’s growing portfolio of healthcare and technology companies, including investments in Simtra BioPharma Solutions, Iodine (Waystar), Cohance Lifesciences (formed following the merger of Suven Pharmaceuticals), Mediq, GS Capsule, and Apollo HealthCo.

The transaction is expected to close in the fourth quarter of 2025, subject to customary regulatory approvals and closing conditions.

Jefferies and Citi served as financial advisors, and Gibson Dunn & Crutcher LLP served as legal advisor to PatientPoint. Solomon Partners served as financial advisor, and Ropes & Gray LLP served as legal advisor to Advent.

About Advent International

Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $94 billion in assets under management* and have made 430 investments across 44 countries.

Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans. We bring hands-on operational expertise to enhance and accelerate businesses.

As one of the largest privately-owned partnerships, our 660+ colleagues leverage the full ecosystem of Advent’s global resources, including our Portfolio Support Group, insights provided by industry expert Operating Partners and Operations Advisors, as well as bespoke tools to support and guide our portfolio companies as they seek to achieve their strategic goals.

To learn more, visit our website or connect with us on LinkedIn.

*Assets under management (AUM) as of March 31, 2025. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles.

About PatientPoint

PatientPoint is the Point of Change company, transforming the healthcare experience through the strategic delivery of behavior-changing content at critical moments of care. As the nation’s largest and most impactful digital network in 30,000 physician offices, we connect patients, providers, and health brands with relevant information that is proven to drive healthier decisions and better outcomes. Learn more at patientpoint.com.

About L Catterton

Catterton is a market-leading consumer-focused investment firm, managing approximately $37 billion of equity capital across three multi-product platforms: private equity, credit, and real estate. The firm’s funds have the ability to invest between $5 million and $5 billion, across the capital structure, in well-positioned consumer businesses. Leveraging deep category insight, operational excellence, and a broad network of strategic relationships, L Catterton’s team of more than 200 investment and operating professionals across 18 offices partners with management teams to drive differentiated value creation across its portfolio. Founded in 1989, the firm has made over 300 investments in some of the world’s most iconic consumer brands. For more information about Catterton, please visit lcatterton.com.

About Littlejohn & Co.

Littlejohn & Co. is a Greenwich, Connecticut-based investment firm focused on private equity and debt investments in growing middle-market industrial and services companies that can benefit from Littlejohn’s 25+ years of operational and sector expertise. With approximately $8 billion in regulatory assets under management, the firm seeks to build sustainable success for its portfolio companies through a disciplined approach to engineering change. For more information about Littlejohn, visit littlejohnllc.com.

Originally announced August 25th, 2025



Thursday, September 25, 2025

< + > CharmHealth Showcases Growth and Innovation at Charmalot 2025

CharmHealth’s annual user conference, Charmalot 2025 (#Charmalot2025), brought providers, administrators, and partners to Berkeley, California, where the company highlighted a broad set of platform enhancements.

Two of the most notable announcements were: CharmHealthSquare, a physician collaboration environment built on Slack technology, and CharmLabs, a new research initiative aimed at bringing advanced analytics and real-world evidence into everyday workflows.

Featured in the video: Pramila Srinivasan and Venky Chellappa from CharmHealth, Dria McCluskey from Sound Physicians, Colleen Burns from Charta Health, Olga Muller from Kepler Team, Jeff Bottari from Klaim, Justyn Dow from VITL, and Poojitha Chettupalli from MarvixAI

Other updates from Charmalot 2025 included:

  • Expansion of CharmHealth Enterprise with new training and development environments
  • Updates to the AI Chatbot that assists patients with scheduling
  • Ongoing investment in AI-enabled tools, including Charm Co-Pilot
  • Broader API capabilities for easier integration with proprietary workflows and external solutions

Beyond the product roadmap, CharmHealth emphasized how these enhancements are resonating with customers.

Customer Growth for CharmHealth                  

The improvements to the company’s API is notable because it aligns with CharmHealth’s efforts to attract larger practices. These APIs were a deciding factor when, Sound Physicians, a multi-state provider, adopted CharmHealth’s EHR this past year. While onsite, Healthcare IT Today had the opportunity to sit down with Sound Physicians.

The challenge ahead for CharmHealth will be balancing new enterprise capabilities with the needs of the independent practices that have been central to its success.

Overall Impression of Charmalot 2025

CharmHealth’s user group conference struck the right balance between educational and promotional. The combination of product announcements, hands-on sessions, and direct access to the CharmHealth team made Charmalot 2025 a valuable experience for attendees.

Learn more about CharmHealth at https://ift.tt/ekBpc1s



< + > Five Simple Guardrails That Keep Low Code Safe in Healthcare IT

The following is a guest article by John Miniadis, Founder and CEO at Stackdrop

In today’s fast-paced healthcare and healthtech landscape, organizations face the constant challenge of innovating quickly while maintaining the highest standards of patient data privacy and security. Low-code platforms have emerged as a powerful catalyst for healthcare digital transformation. They are here to empower teams to quickly build the custom tools they need, enabling rapid app development, streamlined workflows, and tailored operational solutions. But moving fast shouldn’t come at the expense of safeguarding sensitive patient information and complying with stringent healthcare regulations such as HIPAA and GDPR.

By putting a few simple guardrails in place, healthcare organizations can leverage low-code innovation while maintaining strong privacy and compliance. 

Separate Testing from Real Systems

When building apps with low-code tools, segregating development (sandbox) and testing environments from production is paramount. Never build or test with live patient data. For organizations operating multi-site or multi-departmental environments, this segregation should extend further by enforcing strict data access controls based on role and location.

  • Next Step: Create read-only, sanitized test environments populated exclusively with synthetic or anonymized data sets; this not only prevents accidental data leakage but also supports compliance audits
  • Measure Progress: Track the number of users and systems able to access live data and aim for continuous reduction; this control reduces attack surfaces and fosters a culture of responsible data stewardship

Enforce Smarter Access Controls

Low-code platforms often come with powerful access management features that are sometimes underutilized. Use these to further tighten security by setting shorter auto-logout times, typically between 5 and 15 minutes, requiring passwords for sensitive operations, and making use of role-based access control (RBAC) to ensure users only have the minimum privileges necessary for their tasks.

  • Next Step: Configure idle session timeouts (e.g., 5-15 minutes) and require reauthentication for critical tasks within your low-code apps
  • Measure Progress: Monitor how quickly access is revoked when staff leave and review inactive privileged users

Protect Credentials and Secrets

Credential and secret management is a quiet but important pillar of secure low-code apps. Never hardcode passwords, API keys, or tokens in your app’s configuration or code. Instead, store these securely using dedicated secret management features your platform offers, and rotate them regularly. Prefer temporary tokens wherever possible for inter-app connections.

  • Next Step: Identify one key secret in your low-code setup, rotate it, and move it to a secure vault
  • Measure Progress: Track the percentage of credentials securely stored and how often they are refreshed

Make Every Change Traceable

Low-code platforms simplify development but don’t sacrifice oversight. Implement an auditable change management process to maintain control over your apps as they evolve. Maintain an audit trail documenting who approved changes, what was updated, and when. Use release checklists and immutable logging to ensure accountability and compliance with healthcare standards that often require traceability.

  • Next Step: Implement a one-page checklist for app releases that includes approval, ticket numbers, and rollback plans
  • Measure Progress: Confirm your audit logs cover all recent releases

⁠Limit Data Visibility to What’s Needed

Healthcare organizations must carefully architect data access within low-code applications to adhere to the principle of least privilege. Design low-code applications to show users only the patient information necessary for their role. Mask sensitive data when possible, and restrict exporting or downloading data without a clear business justification. These measures protect patient privacy and reduce the risk of accidental or malicious data leakage.

  • Next Step: Pick a frequently used screen in your app, review all displayed data, and hide unnecessary patient details
  • Measure Progress: Track and report on the volume of hidden fields and track data exports without clear reasons

Low-code tools provide immense opportunities for healthcare teams to accelerate innovation and operational efficiency. Yet, privacy and security cannot be an afterthought. Building these foundational practices into your low-code journey is essential to maintaining patient trust, meeting regulatory demands, and avoiding costly breaches.

By implementing these five straightforward but vital steps, healthcare organizations can confidently harness the power of low-code development, fast-tracking digital transformation without compromising the safety and integrity of patient data.

About John Miniadis

John Miniadis is the founder of Stackdrop, a specialist agency that delivers custom internal applications with Retool. His team has helped organizations cut development timelines from months to weeks, reduce operational overhead, and launch low-code tools that scale with business needs, gaining the title of a Certified Retool Agency Partner. By focusing on speed and technical precision, Stackdrop has supported clients across industries, including Healthcare in modernizing workflows and unlocking measurable ROI.



< + > ALIGNMT AI Raises $6.5M Seed Round to Scale AI Risk Monitoring Platform for Healthcare

AIX Ventures Leads Funding Round to Help Healthcare Organizations Slash AI Risk Management Overhead by 50% and Turn Compliance from Bottleneck into Competitive Advantage

ALIGNMT AI, a leading AI compliance platform for healthcare, today announced $6.5 million in seed funding led by AIX Ventures, with participation from Sancus Ventures, Alumni Ventures, and Dent Capital. The funding will accelerate the company’s mission to build trust in AI products through comprehensive, real-time governance that ensures every AI system operates safely, transparently, and equitably.

The Compliance Crisis in AI

Healthcare organizations are increasingly leveraging AI to improve patient outcomes, yet many lack the governance frameworks needed to monitor model behavior, enforce zero-trust safeguards, and maintain regulatory compliance. Meanwhile, new rules, ranging from Coalition for Health AI (CHAI) transparency standards to the EU AI Act, mandate ongoing risk assessments, documentation, and reporting that most organizations aren’t equipped to handle. Without a unified platform to surface emerging AI vulnerabilities, automate safeguards, and generate audit-ready reports, companies face not only compliance fines but also erosion of stakeholder trust and potential harm to the very people they serve.

ALIGNMT’s Unified Platform for AI Risk Mitigation

ALIGNMT AI delivers the executive-level AI oversight that healthcare leaders demand: comprehensive risk mitigation through a governance-first platform that continuously monitors AI systems without exposing sensitive patient data. This automated solution eliminates fragmented manual compliance processes, providing real-time risk detection and streamlined alignment with CHAI, ONC HTI-1, DOJ, and EU AI Act requirements. The outcome is proactive risk management that cuts compliance time in half, prevents costly penalties, and enables confident AI scaling across the enterprise.

“Healthcare leaders are recognizing that AI governance is no longer optional; it’s critical infrastructure that must layer seamlessly onto existing production workflows to enable real-time risk monitoring,” said Andreea Bodnari, CEO at ALIGNMT AI. “This funding allows us to accelerate our platform development and expand our partnerships with leading healthcare institutions.”

The company is already working with major health systems, payers, and health IT companies like electronic medical record platforms and AI developers. ALIGNMT AI’s work leading the industry towards AI assurance has gained significant recognition and is the focus of a case study being prepared by Harvard Business School for winter 2025.

“ALIGNMT.AI is the transformative solution hospitals and healthcare systems have been waiting for as they scale AI,” said Krish Ramadurai, Partner at AIX Ventures and lead investor in their seed round. “It gives clinical and compliance teams real-time visibility into every AI tool they deploy, surfacing issues instantly and helping them avoid costly mistakes. We’re already seeing healthcare providers cut compliance prep time by half, enabling them to confidently roll out new AI solutions that improve patient care safely and effectively.”

The seed funding will enable ALIGNMT AI to expand its engineering team, accelerate product development, and scale partnerships with healthcare organizations seeking to deploy AI responsibly while maintaining operational efficiency and patient safety.

Healthcare organizations can learn more at alignmt.ai.

About ALIGNMT AI

ALIGNMT AI provides comprehensive AI governance and risk management solutions that safeguard artificial intelligence across its entire lifecycle. The platform automates compliance workflows, continuous risk monitoring, and transparency reporting, transforming fragmented processes into a unified, scalable system. Certified by the Coalition for Healthcare AI and trusted by leading healthcare institutions, ALIGNMT AI helps organizations deploy AI responsibly while maintaining operational efficiency and patient safety. Learn more or request a demo at alignmt.ai.

Originally announced September 1st, 2025



< + > Are You Experiencing Data Chaos or Clean Identity with Your EMPI?

Identity management is one of the most challenging problems healthcare IT organizations face.  For those not familiar with identity manageme...